切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (05) : 625 -628. doi: 10.3877/cma.j.issn.2095-3232.2024.05.006

专家论坛

胰头癌淋巴结清扫再思考
郭诗翔1, 谭明达1, 王槐志1,()   
  1. 1. 400016 重庆医科大学;400714 中国科学院重庆绿色智能技术研究院;400714 中国科学院大学重庆学院;401147 重庆市人民医院肝胆胰腺外科研究所
  • 收稿日期:2024-05-15 出版日期:2024-10-10
  • 通信作者: 王槐志
  • 基金资助:
    国家自然科学基金(82373128); 重庆英才计划-青年拔尖人才"包干制"项目(cstc2022ycjh-bgzxm0137); 重庆市渝中区自然科学基金(20210160); 重庆市科卫联合医学科研项目(2024MSXM174)

Rethinking lymph node dissection in pancreatic head cancer

Shixiang Guo1, Mingda Tan1, Huaizhi Wang1,()   

  1. 1. Chongqing Medical University, Chongqing 400016, China; Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing 400714, China; Chongqing School, University of Chinese Academy of Sciences, Chongqing 400714, China; Institute of Hepatobiliary and Pancreatic Surgery, Chongqing General Hospital, Chongqing 401147, China
  • Received:2024-05-15 Published:2024-10-10
  • Corresponding author: Huaizhi Wang
引用本文:

郭诗翔, 谭明达, 王槐志. 胰头癌淋巴结清扫再思考[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 625-628.

Shixiang Guo, Mingda Tan, Huaizhi Wang. Rethinking lymph node dissection in pancreatic head cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 625-628.

胰腺癌是一种高致死率的消化道恶性肿瘤,起病隐匿,因缺乏早期高敏度特异性诊断标志物,大部分患者就诊时已处于中晚期,根治性手术切除率低,预后极差,5年生存率低于10%。根治性切除术是治愈胰腺癌的唯一有效途径,由于其恶性程度高且具有高度嗜神经性,早期极易发生原位复发、区域淋巴结或远处转移,故淋巴结清扫的彻底性对于患者远期疗效及预后尤为重要。随着现代外科的不断发展,各中心不同胰腺外科医师对于胰头癌淋巴结清扫内涵理解不同,相关研究存在明显的异质性。本文结合目前国内外研究进展及本中心临床实践,详述胰头癌淋巴结清扫在胰腺癌中的应用。

Pancreatic cancer is a malignant digestive tract tumor with high mortality and hidden onset. Due to the lack of early high-sensitivity specific diagnostic markers, most patients are diagnosed in the middle and late stage. Radical resection rate is low, clinical prognosis is extremely poor, and the 5-year survival rate is less than 10%. Radical resection is the only effective treatment for pancreatic cancer. Because of high-degree malignancy and high-degree neurophilia, the risk of local recurrence, regional lymph node or distant metastases is high in the early stage. Hence, the completeness of lymph node dissection plays a significant role in the long-term efficacy and prognosis of patients. With persistent development of modern surgery, pancreatic cancer surgeons from different centers have different understandings of the connotation of lymph node dissection for pancreatic head cancer, and relevant studies yield high heterogeneity. Based on the latest research progress at home and abroad and clinical practice of our center, the application of lymph node dissection of pancreatic head cancer in pancreatic cancer was explicitly illustrated in this article.

[1]
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA A Cancer J Clin, 2022, 72(1):7-33.
[2]
Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment[J]. Technol Cancer Res Treat, 2020, 19: 1533033820962117.
[3]
Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis[J]. Cancer Lett, 2021, 520:1-11.
[4]
Tempero MA. NCCN guidelines updates: pancreatic cancer[J]. J Natl Compr Canc Netw, 2019, 17(5.5):603-605.
[5]
Masiak-Segit W, Rawicz-Pruszyński K, Skórzewska M, et al. Surgical treatment of pancreatic cancer[J]. Pol Przegl Chir, 2018, 90(2):45-53.
[6]
Min SK, You Y, Choi DW, et al. Prognosis of pancreatic head cancer with different patterns of lymph node metastasis[J]. J Hepatobiliary Pancreat Sci, 2022, 29(9):1004-1013.
[7]
Karunakaran M, Barreto SG. Surgery for pancreatic cancer: current controversies and challenges[J]. Future Oncol, 2021, 17(36):5135-5162.
[8]
Varshney VK. Pancreatic head cancer with different patterns of lymph node metastasis[J]. J Hepatobiliary Pancreat Sci, 2022, 29(11):e116.
[9]
Arrington AK, Price ET, Golisch K, et al. Pancreatic cancer lymph node resection revisited: a novel calculation of number of lymph nodes required[J]. J Am Coll Surg, 2019, 228(4):662-669.
[10]
Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)[J]. Surgery, 2014, 156(3):591-600.
[11]
Ignjatovic I, Knezevic S, Knezevic D, et al. Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma[J]. J BUON, 2017, 22(1):232-238.
[12]
Pu N, Mu S, Fang Y, et al. Survival outcomes of pancreaticoduodenectomy versus extended pancreaticoduodenectomy procedure for pancreatic head carcinoma: a propensity score matching study[J]. Transl Cancer Res, 2020, 9(3):1476-1486.
[13]
Lin Q, Zheng S, Yu X, et al. Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial[J]. Cancer Commun, 2023, 43(2):257-275.
[14]
Guo X, Song Y, Xu P, et al. Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patients: retrospective cohort study[J]. Int J Surg, 2023, 109(7):1852-1862.
[15]
Wang Z, Ke N, Wang X, et al. Optimal extent of lymphadenectomy for radical surgery of pancreatic head adenocarcinoma: 2-year survival rate results of single-center, prospective, randomized controlled study[J]. Medicine, 2021, 100(35):e26918.
[16]
Imamura T, Yamamoto Y, Sugiura T, et al. Reconsidering the optimal regional lymph node station according to tumor location for pancreatic cancer[J]. Ann Surg Oncol, 2021, 28(3):1602-1611.
[17]
Qian L, Xie J, Xu Z, et al. The necessity of dissection of No. 14 lymph nodes to patients with pancreatic ductal adenocarcinoma based on the embryonic development of the head of the pancreas[J]. Front Oncol, 2020, 10: 1343.
[18]
Mirkin KA, Hollenbeak CS, Wong J. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer[J]. J Surg Res, 2017, 220: 12-24.
[19]
Rahim MK, Okholm TLH, Jones KB, et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes[J]. Cell, 2023, 186(6):1127-1143, e18.
[20]
杨尹默, 李宝毅, 马永蔌. 胰腺癌免疫治疗现状与进展[J]. 中华普通外科杂志, 2023, 38(5):321-325
[21]
Huang Q, Wu X, Wang Z, et al. The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes[J]. Cell, 2022, 185(22):4049-4066, e25.
[1] 王佳佳, 詹韵韵, 姜凡, 孙碧云, 毕玉, 李如冰, 彭梅. Peyton四步教学法在超声住院医师规范化培训颈部淋巴结分区中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 814-818.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[5] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[6] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[7] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[8] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[11] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[12] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[13] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?